Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name: Propafenone hydrochloride |
Other Name:-[2-[2-Hydroxy-3-(Propylamino)Propoxy]Phenyl]-3-Phenylpropan-1-OneHydrochloride |
Appearance:White powder |
CAS:34183-22-7 |
M.F.:C21H28ClNO3 |
M.W.:377.9 |
Specification:99% |
Propafenone is in a group of drugs called Class IC anti-arrhythmics. It affects the way your heart beats.
Propafenone is used in certain situations to prevent serious heart rhythm disorders.
Product Name | CAS No. | Product Name | CAS No. |
Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
ITEM | SPECIFICATION | RESULT | METHOD |
Appearance | White powder, neutral odor, highly hygroscopic | Conforms | Visual |
Identification | Standard solution and test solution same spot,RF | Conforms | TLC |
Specific Optical | -2.4°~ -2.8° | -2.72° | |
Heavy metals (as PB) | ≤10ppm | Conforms | AAS |
Sulfate (SO4) | ≤0.02% | Conforms | Colorimetry |
Chloride (Cl) | ≤0.02% | Conforms | Colorimetry |
Phosphate Ion (P) | ≤5ppm | Conforms | Colorimetry |
Residual solvent(ethanol) | ≤1.0% | Conforms | HS-GC |
pH | 4.5~7.0 | 5.10 | |
Related substance | Spot not bigger than standard solution spot | No spot | TLC |
Water Content | ≤2% | 0.26% | KF |
Assay (dried basis) | 98.0%--102.0% | 99.48% | Potentiometric titration |
Assay (dried basis) | 98.5%--100% | 99.2% | HPLC |
Function:
For the prevention and treatment of ventricular or supraventricular ectopic, tachycardia, preshock
syndrome and the prevention of ventricular fibrillation.
Uses for the prevention and treatment of ventricular or supraventricular ectopic Pollex, heart op
tachycardia, WPW syndrome and shock cardioversion condensation prevention of ventricular fibrillation
episodes